ACAD
Selling Acadia Pharmaceuticals out of my Jubak Picks portfolio
Today I'm selling Acadia Pharmaceuticals (ACAD) out of my Jubak Picks portfolio. I have a 13.52% loss on this position since I added the shares to the portfolio on November 15, 2016. There are short- and long-range reasons to sell. From a short-range perspective for...Today should be a big day for biotech
JPMorgan Chase holds its big biotech conference today, Monday January 9, and last week’s momentum in the sector as well as likely upbeat guidance to begin the conference at 10:30 a.m. Eastern time from Celgene (CELG) should have the sector on the move.
Acadia Pharmaceuticals is my first Trump stock pick
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Sector Monday: Healthcare, drugs, and biotech, Oh! My!
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Jim’s Stock Alerts
Download Jim’s eBook for Free
